EXACT Therapeutics AS announced the appointment of John Edminson as Chief Financial Officer, effective 1 October 2022. John is a graduate from the Norwegian School of Economics with a Master in Auditing and Accounting and he built his career foundations working in audit at KPMG, which included 1.5 years in Boston, USA. He subsequently gained experience in both finance and operations in a variety of companies, including Telenor, ACNielsen, and Kistefos, before taking on CFO roles in PatientSky and Questback.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 NOK | 0.00% | -2.86% | -43.33% |
1st Jan change | Capi. | |
---|---|---|
-43.33% | 19.75M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EXTX Stock
- News EXACT Therapeutics
- EXACT Therapeutics AS Appoints John Edminson as Chief Financial Officer, Effective 1 October 2022